opioids

Indivior pays $300m to settle Suboxone marketing allegations

https://pharmaphorum.com/news/indivior-pays-300m-to-settle-suboxone-marketing-allegations/

Ohio is third state to fund Pear’s digital therapeutics to tackle addiction

https://pharmaphorum.com/news/ohio-is-third-state-to-fund-pears-digital-therapeutics-to-tackle-addiction/

Top-Level industry professionals to speak at Pain Therapeutics Conference in 2 weeks

https://pharmaphorum.com/partner-content/top-level-industry-professionals-to-speak-at-pain-therapeutics-conference-in-2-weeks/

Registration Opens for SMi’s 20th Annual Pain Therapeutics Conference

https://pharmaphorum.com/partner-content/registration-opens-for-smis-20th-annual-pain-therapeutics-conference/

Washington State is latest to sue Janssen over opioid marketing

https://pharmaphorum.com/news/washington-state-is-latest-to-sue-jj-over-opioid-marketing/

J&J brushes off concerns over talc, opioid and Risperdal litigation

https://pharmaphorum.com/news/jj-brushes-off-concerns-over-litigation/

Facing opioid liability risk, Mallinckrodt stalls generics split

https://pharmaphorum.com/news/facing-opioid-liability-risk-mallinckrodt-stalls-generics-split/

FDA to reconsider Braeburn’s opioid addiction drug after court ruling

https://pharmaphorum.com/news/fda-to-reconsider-braeburns-opioid-addiction-drug-after-court-ruling/

Drug firm prosecuted for distributing opioids illegally

https://pharmaphorum.com/news/drug-firm-prosecuted-for-distributing-opioids-illegally/

1 2 3

Close in 10 seconds

Pharmaphorum.com

Search